HOUT-28. FIRST-LINE TEMOZOLOMIDE VS PCV FOR LOW GRADE GLIOMAS: A 11 YEARS REAL-WORLD DATA FROM CHUM, UNIVERSITY CENTER

BACKGROUND: Before 2012, Temozolomide (TMZ) was used for low-grade gliomas (LGG) to avoid Lomustine toxicity. After 2012 RTOG data, Procarbazine, Lomustine and Vincristine (PCV) given sequentially with radiotherapy became standard treatment with the side effects burden associated. METHODS: We retros...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Nait Ajjou, Myriam, Assad, Anis, Letourneau Guillon, Laurent, Belanger, Karl, Lemieux Blanchard, Emilie, Lemieux, Bernard, Bahary, Jean-Paul, G Masucci, Laura, Roberge, David, Menard, Cynthia, Lambert, Carole, Moumdjian, Robert, Berthelet, France, Ben-Abdallah, Meriem, De Guise, Jacques, Florescu, Marie
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Health Outcome Measures
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847185/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.493
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados